ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy.
Venetis K, Cursano G, Scafetta R, Giachetti PPMB, Concardi A, De Camilli E, D'Ercole M, Mane E, Frascarelli C, Marra A, Gandini S, Pepe F, Scagnoli S, Rossi SM, Troiano R, Speziale E, De Angelis C, Troncone G, Malapelle U, Perrone G, Botticelli A, Viale G, Curigliano G, Guerini Rocco E, Criscitiello C, Fusco N.
Venetis K, et al. Among authors: d ercole m.
Breast Cancer Res. 2025 May 14;27(1):79. doi: 10.1186/s13058-025-02020-x.
Breast Cancer Res. 2025.
PMID: 40369610
Free PMC article.